Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands

A.W. Musschenga, H.E.M. van Luijn, N.K. Aaronson, R.B. Keus

Research output: Contribution to JournalArticleAcademic

36 Downloads (Pure)
Original languageEnglish
Pages (from-to)13-19
JournalIRB: Ethics and Human Behavior
Issue number29
Publication statusPublished - 2007

Cite this